Publication

Development and Implementation of Multiplex TaqMan Array Cards for Specimen Testing at Child Health and Mortality Prevention Surveillance Site Laboratories

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Maureen H. Diaz, Centers for Disease Control and PreventionJessica L. Waller, Centers for Disease Control and PreventionM. Jordan Theodore, IHRC IncNishi Patel, IHRC IncBernard J. Wolff, Centers for Disease Control and PreventionAlvaro J. Benitez, Centers for Disease Control and PreventionTimothy Morris, Task Force for Global HealthPratima L. Raghunathan, Centers for Disease Control and PreventionRobert Breiman, Emory UniversityCynthia Whitney, Emory UniversityDianne M. Blau, Centers for Disease Control and PreventionJonas W. Winchell, Centers for Disease Control and Prevention
Language
  • English
Date
  • 2019-10-15
Publisher
  • Oxford University Press Inc.
Publication Version
Copyright Statement
  • © 2019 Published by Oxford University Press for the Infectious Diseases Society of America 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 69
Issue
  • Suppl 4
Start Page
  • S311
End Page
  • S321
Grant/Funding Information
  • This work was supported by the Bill & Melinda Gates Foundation [OPP1126780].
Supplemental Material (URL)
Abstract
  • Child Health and Mortality Prevention Surveillance (CHAMPS) laboratories are employing a variety of laboratory methods to identify infectious agents contributing to deaths of children <5 years old and stillbirths in sub-Saharan Africa and South Asia. In support of this long-term objective, our team developed TaqMan Array Cards (TACs) for testing postmortem specimens (blood, cerebrospinal fluid, lung tissue, respiratory tract swabs, and rectal swabs) for >100 real-time polymerase chain reaction (PCR) targets in total (30-45 per card depending on configuration). Multipathogen panels were configured by syndrome and customized to include pathogens of significance in young children within the regions where CHAMPS is conducted, including bacteria (57 targets covering 30 genera), viruses (48 targets covering 40 viruses), parasites (8 targets covering 8 organisms), and fungi (3 targets covering 3 organisms). The development and application of multiplex real-time PCR reactions to the TAC microfluidic platform increased the number of targets in each panel while maintaining assay efficiency and replicates for heightened sensitivity. These advances represent a substantial improvement in the utility of this technology for infectious disease diagnostics and surveillance. We optimized all aspects of the CHAMPS molecular laboratory testing workflow including nucleic acid extraction, quality assurance, and data management to ensure comprehensive molecular testing of specimens and high-quality data. Here we describe the development and implementation of multiplex TACs and associated laboratory protocols for specimen processing, testing, and data management at CHAMPS site laboratories.
Author Notes
  • Correspondence: J. M. Winchell, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS G-03, Atlanta, GA 30329 (jwinchell@cdc.gov)
Keywords
Research Categories
  • Health Sciences, Human Development
  • Health Sciences, Epidemiology
  • Health Sciences, Public Health
  • Biology, Microbiology

Tools

Relations

In Collection:

Items